A detailed history of Jones Financial Companies Lllp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 132 shares of CORT stock, worth $7,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132
Previous 301 56.15%
Holding current value
$7,762
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$29.51 - $46.26 $4,987 - $7,817
-169 Reduced 56.15%
132 $6,000
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $6,685 - $10,378
301 New
301 $9,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.3B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.